Chamber Raises $60 Million in Series A Funding to Drive the Future of Cardiology Value-Based Care

Chamber在A轮融资中筹集了6000万美元，以推动基于价值的心脏病学护理的未来发展。

Led by Frist Cressey Ventures, with investments from General Catalyst and other prominent investors, the round enables Chamber to continue to scale rapidly nationwide

由Frist Cressey Ventures领投，General Catalyst和其他知名投资者参投，本轮融资使Chamber能够继续在全国范围内快速扩展。

WASHINGTON, February 4, 2026-- Chamber today announced it has raised $60 million in Series A funding to support cardiologists and health plans in managing patients with heart disease under value-based care models. The round was led by Frist Cressey Ventures, with participation from existing investors General Catalyst, AlleyCorp, American Family Ventures, and Company Ventures, as well as strategic participation from Optum Ventures, Healthworx Ventures, and additional investment from Black Opal Ventures.

华盛顿，2026年2月4日——Chamber今天宣布，已在A轮融资中筹集了6000万美元，用于支持心脏病学家和健康计划在基于价值的护理模式下管理心脏病患者。本轮融资由Frist Cressey Ventures领投，现有投资者General Catalyst、AlleyCorp、American Family Ventures和Company Ventures参与，Optum Ventures、Healthworx Ventures战略参与，Black Opal Ventures追加投资。

The financing also includes debt from HSBC Innovation Banking..

融资还包括来自汇丰创新银行的债务。

The Series A funding will be used to expand partnerships with health plans and cardiology practices, grow into additional markets, and continue building Chamber's clinical, operational, and technology teams.

A轮融资将用于扩大与健康计划和心脏病学实践的合作，拓展更多市场，并继续建设Chamber的临床、运营和技术团队。

'Chamber is focused on building the infrastructure that helps cardiologists succeed in value-based care, supports more predictable performance for health plans, and ultimately delivers a better experience for patients with heart disease' said George Aloth, Co-Founder and CEO of Chamber.

“Chamber 专注于构建帮助心脏病学家在价值导向型医疗中取得成功的基础设施，支持健康计划更可预测的绩效，并最终为心脏病患者提供更好的体验。”Chamber 联合创始人兼首席执行官乔治·阿洛斯 (George Aloth) 表示。

Chamber partners with both payers and cardiologists to support value-based care programs focused on the long-term management of cardiovascular disease. Its cardiology-focused data and intelligence platform, designed to support clinicians within existing workflows, integrates workflow-native AI to prioritize high-risk patients, identify gaps in guideline-directed therapy, and reduce manual chart review.

Chamber与支付方和心脏病专家合作，支持以价值为基础的护理项目，重点关注心血管疾病的长期管理。其专注于心脏病学的数据和智能平台旨在支持临床医生在现有工作流程中的工作，集成了工作流原生AI，用于优先处理高风险患者、识别指南导向治疗中的差距，并减少手动图表审查。

This combined with Chamber's operational infrastructure helps reduce preventable complications and hospital use, improve patient experience, and provide health plans with clearer visibility into cardiovascular performance and total cost of care..

这一成果结合Chamber的运营基础设施，有助于减少可预防的并发症和住院治疗，改善患者体验，并为健康计划提供更清晰的心血管绩效和护理总成本的可见性。

'Cardiovascular care generates enormous amounts of data, but clinicians don't need more data but rather a clearer signal,' said Sameer Sheth, M.D., Co-Founder, President & CMO of Chamber.

“心血管护理产生了大量的数据，但临床医生需要的不是更多的数据，而是更清晰的信号，”Chamber公司的联合创始人、总裁兼首席医疗官Sameer Sheth博士说道。

Cardiovascular disease remains one of the largest drivers of healthcare cost and utilization in the U.S. Cardiologists are increasingly responsible for older, higher-risk patients, yet often lack timely data and support outside of office visits. These gaps contribute to delayed interventions, missed follow-ups, avoidable hospitalizations, and rising costs that traditional fee-for-service care was not designed to address..

心血管疾病仍然是美国医疗成本和资源利用的主要驱动因素之一。心脏科医生越来越多地负责照顾年纪更大、风险更高的患者，但往往缺乏及时的数据和支持，尤其是在非门诊时段。这些缺口导致干预延迟、随访遗漏、可避免的住院增加以及传统按服务收费模式无法解决的不断上升的成本。

'At FCV, we invest in companies transforming care delivery in healthcare's most consequential areas, and Chamber exemplifies that mission,' said Senator Bill Frist, M.D., Co-Founder and Managing Partner at Frist Cressey Ventures and a nationally recognized heart and lung transplant surgeon. 'Cardiovascular disease is the largest driver of U.S.

“在FCV，我们投资于那些在医疗保健最关键领域变革护理服务的公司，而Chamber正是这一使命的典范，”参议员、医学博士比尔·弗里斯特（Bill Frist）表示，他是Frist Cressey Ventures的联合创始人兼管理合伙人，同时也是全国知名的心脏和肺移植外科医生。“心血管疾病是美国医疗健康领域最大的驱动因素。”

healthcare spend, yet care delivery remains fragmented and fee-for-service–driven. The Chamber platform brings value-based care to cardiology, delivering better outcomes and improved quality of life for patients and their families.'.

医疗支出，但医疗服务的提供仍然分散且以收费服务为主。Chamber 平台将基于价值的护理引入心脏病学领域，为患者及其家庭带来更好的治疗效果和生活质量提升。

Chamber currently supports patients through multiple payer partnerships and works with a network of more than 500 cardiologists across seven states, with plans for continued national expansion.

Chamber目前通过多个支付方合作伙伴关系为患者提供支持，并与横跨七个州的500多名心脏病学家组成的网络合作，计划继续进行全国范围的扩展。

For more information, visit www.chambercardio.com.

欲了解更多信息，请访问 www.chambercardio.com。

About Chamber

关于舱室

Chamber is dedicated to supporting cardiology practices through technology-enabled delivery. Co-founded by healthcare industry leaders George Aloth, Dr. Sameer Sheth, and Dr. Jeffrey De Flavio, Chamber empowers cardiologists to thrive in a value-based care, ensuring improved patient outcomes and increased practice success..

Chamber致力于通过技术赋能支持心脏科诊所的运营。该公司由医疗行业领军人物乔治·阿洛斯、萨米尔·谢思博士和杰弗里·德·弗拉维奥博士共同创立，Chamber助力心脏科医生在基于价值的医疗体系中蓬勃发展，确保患者获得更好的治疗效果，并提升诊所的成功率。